Targeting vaccination against novel infections: Risk, age and spatial structure for pandemic influenza in Great Britain

Journal of the Royal Society Interface

Volumn 8, Issue 58, 2011, Pages 661-670

  Keeling, Matt J ^a   White, Peter J ^b,c  

^a UNIVERSITY OF WARWICK   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Age structure; Influenza; Novel infections; Spatial structure; Targeting; Vaccination

Indexed keywords

UNCERTAINTY ANALYSIS; VIRUSES;

AGE STRUCTURES; INFLUENZA; NOVEL INFECTIONS; SPATIAL STRUCTURE; TARGETING; VACCINATION;

OPTIMIZATION;

INFLUENZA VACCINE;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CHILD; HUMAN; INFECTION RISK; INFLUENZA A (H1N1); INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; PANDEMIC; PATIENT SELECTION; PRESCHOOL CHILD; SCHOOL CHILD; UNITED KINGDOM;

ORTHOMYXOVIRIDAE;

EID: 79953244642     PISSN: 17425689     EISSN: 17425662     Source Type: Journal    
DOI: 10.1098/rsif.2010.0474     Document Type: Article

References (29)

1. Anderson, R. & May, R. 1982 Directly transmitted infectious diseases: control by vaccination. Science 215, 1053-1060. (doi:10.1126/science.7063839)
2. McLean, A. 1998 Vaccines and their impact on the control of disease. Br. Med. Bull. 54, 545-556.
3. Fine, P. 1993 Herd immunity: history, theory, practice. Epidemiol. Rev. 15, 265-302.
4. Fenner, F., Henderson, D., Arita, L., Jezek, Z. & Ladnyi, L. 1988 Smallpox and its eradication. Geneva, Switzerland: World Health Organisation.
5. Fine, P. & Clarkson, J. 1983 Measles in England and Wales III: assessing published predictions of the impact of vaccination in incidence. Int. J. Epidemiol. 12, 332-339. (doi:10.1093/ije/12.3.332)
6. McLean, A. & Anderson, R. M. 1988 Measles in developing countries part II. The predicted impact of mass vaccination. Epidem. Infect. 100, 419-442. (doi:10.1017/S0950268800067170)
7. Jit, M., Choi, Y. H. & Edmunds, W. J. 2008 Economic evaluation of human papillomavirus vaccination in the United Kingdom. Brit. Med. J. 337, a769. (doi:10.1136/bmj.a769)
8. Baguelin, M., Hoek, A. J. V., Jit, M., Flasche, S., White, P. J. & Edmunds, W. J. 2010 Vaccination against pandemic influenza A/H1N1v in England: a real-time economic evaluation. Vaccine 28, 2370-2384. (doi:10.1016/j.vaccine. 2010.01.002)
9. Donaldson, L. 2010 Chief medical officer's fortnightly bulletin for journalists. (18 March 2010). See http://webarchive.nationalarchives.gov.uk/+/ www.dh.gov.uk/en/Publichealth/Flu/Swineflu/DH-112078.
10. Department of Health. 2010 Pandemic H1N1 vaccine uptake figures for England by SHA and PCT. See http://www.dh.gov.uk/en/Publicationsandstatistics/ Publications/PublicationsPolicyAndGuidance/DH-114203.
11. Ferguson, N. M., Cummings, D. A. T., Fraser, C., Cajka, J. C., Cooley, P. C. & Burke, D. S. 2006 Strategies for mitigating an influenza pandemic. Nature 442, 448-452. (doi:10.1038/nature04795)
12. Hall, I. M., Egan, J. R., Barrass, I., Gani, R. & Leach, S. 2007 Comparison of smallpox outbreak control strategies using a spatial metapopulation model. Epidemiol. Infect. 135, 1133-1144. (doi:10.1017/ S0950268806007783)
13. Grais, R. F., Conlan, A. J. K., Ferrari, M. J., Djibo, A., Menach, A. L., Bjornstad, O. N. & Grenfell, B. T. 2008 Time is of the essence: exploring a measles outbreak response vaccination in Niamey, Niger. J. R. Soc. Interface 5, 67-74. (doi:10.1098/rsif.2007.1038)
14. House, T. & Keeling, M. J. 2009 Household structure and infectious disease transmission. Epidemiol. Infect. 137, 654-661. (doi:10.1017/ S0950268808001416)
15. Medlock, J. & Galvani, A. P. 2009 Optimizing influenza vaccine distribution. Science 325, 1705-1708. (doi:10.1126/science.1175570)
16. Ghani, A. C. et al. 2009 The early transmission dynamics of H1N1pdm influenza in the United Kingdom. PLoS Curr. Influenza (RRN1130). (doi:10.1371/currents.RRN1130)
17. Kermack, W. O. & McKendrick, A. G. 1927 A contribution to the mathematical theory of epidemics. Proc. R. Soc. Lond. A 115, 700-721. (doi:10.1098/rspa.1927.0118)
18. Anderson, R. M. & May, R. 1992 Infectious diseases of humans. Oxford, UK: Oxford University Press.
19. Keeling, M. & Rohani, P. 2008 Modeling infectious diseases in humans and animals. Princeton, NJ: Princeton University Press.
20. Ferguson, N., Keeling, M., Edmunds, W., Gant, R., Grenfell, B., Anderson, R. & Leach, S. 2003 Planning for smallpox outbreaks. Nature 425, 681-685. (doi:10.1038/nature02007)
21. Keeling, M. J., Woolhouse, M. E. J., May, R. M., Davies, G. & Grenfell, B. T. 2003 Modelling vaccination strategies against foot-and-mouth disease. Nature 421, 136-142. (doi:10.1038/nature01343)
22. Dushoff, J., Plotkin, J. B., Viboud, C., Simonsen, L., Miller, M., Loeb, M. & Earn, D. J. D. 2007 Vaccinating to protect a vulnerable subpopulation. PLoS. Med. 4, 921-927. (doi:10.1371/journal.pmed.0040174)
23. Mylius, S. D., Hagenaars, T. J., Lugner, A. K. &Wallinga, J. 2008 Optimal allocation of pandemic influenza vaccine depends on age, risk and timing. Vaccine 26, 3742-3749. (doi:10.1016/j.vaccine.2008.04.043)
24. Mossong, J. et al. 2008 Social contacts and mixing patterns relevant to the spread of infectious diseases. PLoS Med. 5, 381-391. (doi:10.1371/journal. pmed.0050074)
25. Muller, J. 1998 Optimal vaccination patterns in age-structured populations. Siam J. Appl. Math. 59, 222-241. (doi:10.1137/S0036139995293270)
26. Wallinga, J., van Boven, M. & Lipsitch, M. 2010 Optimizing infectious disease interventions during an emerging epidemic. Proc. Natl Acad. Sci. USA 107, 923-928. (doi:10.1073/pnas.0908491107)
27. Goldstein, E., Apolloni, A., Lewis, B., Miller, J. C., Macauley, M., Eubank, S., Lipsitch, M. & Wallinga, J. 2010 Distribution of vaccine/antivirals and the 'least spread line' in a stratified population. J. R. Soc. Interface 7, 755-764. (doi:10.1098/rsif.2009.0393)
28. May, R. & Anderson, R. 1984 Spatial heterogeneity and the design of immunization programs. Math. Biosci. 72, 83-111. (doi:10.1016/0025-5564(84) 90063-4)
29. Wu, J. T., Riley, S. & Leung, G. M. 2007 Spatial considerations for the allocation of pre-pandemic influenza vaccination in the United States. Proc. R. Soc B 274, 2811-2817. (doi:10.1098/rspb.2007.0893)